GSK acquires Nuvalent for $10.6 billion to rebuild its oncology business
GSK acquires Nuvalent for $10.6 billion to rebuild its oncology business
- Read at Crypto Briefing
- Wed, 10 Jun 2026 01:06:25 +0000
GSK acquires Nuvalent for $10.6 billion to rebuild its oncology business